Measuring the outcome of clinical trials
Clinical trials for autism drugs have been plagued with problems: bad design, the wrong measures, too broad a range of participants. All that is finally starting to change.
Clinical trials for autism drugs have been plagued with problems: bad design, the wrong measures, too broad a range of participants. All that is finally starting to change.
Some women who have children with autism look in the mirror, an accounting firm predicts profit from employees on the spectrum, and 2016 was a slow year for drug approvals.
The books, shows and movies that most accurately portray autism are those that don’t dwell on the condition.
Peruse our picks for the best science photos published on Spectrum this year.
We took note of our favorite quotes from articles we published this year.
Advances in autism research usually take center stage on Spectrum, but we don’t often talk about what it takes to get there: years training for a faculty job, long hours at the bench, deferred marriage or children, missed vacations, long-distance relationships and, perhaps, complex childcare arrangements.
In this series, we tell four stories about the connections and conflicts between scientists and parents.
There has been a resurgence of interest in monkey models for autism. This special report rounds up the results.